Visceral Fat Reduction Extensive Research Extensive clinical research has established Tesamorelin as the only FDA-approved therapy for visceral fat reduction in HIV-associated lipodystrophy, with pivotal trials demonstrating mean reductions of 15-18% in trunk fat over 26 weeks of treatment
In this case, with the usual dose of 30 mcg, you should take the shot for 5-10 days
Midlife adults often want better focus and mood, especially when long workdays meet changing sleep patterns
Review our triple-agonist mechanism guide for detailed receptor analysis
Registered 503B, third-party lab tested.
Importantly, no significant impact on food intake and no observable adverse effects were reported, suggesting a metabolic rather than appetite-mediated mechanism of action